Browsing by author "Llorca, P. M."

Repository

How to publish

Resources

FAQs

Now showing items 1-6 of 6

Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study

Llorca, P. M.; Bobes, Julio; Fleischhacker, W. W.; Heres, S.; Moore, N.; Bent Ennakhil, N.; Sapin, C.; Loze, J. Y.; Nylander, A. G.; Patel, M. X. (2018)
Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study

Tripoli, G.; Quattrone, D.; Ferraro, L.; Gayer Anderson, C.; Rodríguez, V.; La Cascia, C.; La Barbera, D.; Sartorio, C.; Seminerio, F.; Tarricone, I.; Berardi, D.; Szöke, A.; Arango, C.; Tortelli, A.; Llorca, P. M.; De Haan, L.; Velthorst, E.; Bobes, Julio (2020)
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study

Misra, S.; Gelaye, B.; Williams, D. R.; Koenen, K. C.; Borba, C. P.C.; Quattrone, D.; Di Forti, M.; Tripoli, G.; La Cascia, C.; La Barbera, D.; Ferraro, L.; Tarricone, I.; Berardi, D.; Lasalvia, A.; Tosato, S.; Szöke, A.; Llorca, P. M.; Arango, C.; Tortelli, A.; De Haan, L.; Velthorst, E.; Bobes, Julio (2021)
Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use

García-Portilla González, María Paz; Llorca, P. M.; Maina, G.; Bozikas, V. P.; Devrimci Ozguven, H.; Kim, S. W.; Bergmans, P.; Usankova, I.; Cherubin, P.; Pungor, K. (2019)
Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: impact on caregiver burden

Maina, G.; García-Portilla González, María Paz; Llorca, P. M.; Bozikas, V. P.; Devrimci-Ozguven, H.; Kim, S. W.; Bergmans, P.; Strulev, V.; Cherubin, P.; Pungor, K. (2019)
Symptomatic remission with paliperidone palmitate 3-monthly formulation in schizophrenia patients in a clinical practice setting

García-Portilla González, María Paz; Llorca, P. M.; Maina, G.; Bozikas, V. P.; Devrimci Ozguven, H.; Kim, S. W.; Bergmans, P.; Usankova, I.; Cherubin, P.; Najarian, D.; Pungor, K. (2019)

Browsing by author "Llorca, P. M."

Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study ﻿

Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study ﻿

Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study ﻿

Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use ﻿

Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: impact on caregiver burden ﻿

Symptomatic remission with paliperidone palmitate 3-monthly formulation in schizophrenia patients in a clinical practice setting ﻿

Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study

Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study

Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study

Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use

Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: impact on caregiver burden

Symptomatic remission with paliperidone palmitate 3-monthly formulation in schizophrenia patients in a clinical practice setting